CSPG4 and cancer: CSPG4 CAR T cells demonstrated strong antitumor activity against all the tested cell lines, by achieving near complete eradication of target cells at high ratios (cancer cell lysis of 72.2 ± 15.6% at the 1:1 E: T and 50.3 ± 20.7% at the 1:2 E: T) (Fig. 2C).